Verano Holdings (VRNO) Stock Analysis & Winston Score
Verano Holdings is a cannabis company that grows, makes, and sells marijuana products across the United States. Its products include flower, edibles, vapes, and concentrates sold under brand names like Verano, Encore, and MÜV. It sells directly to consumers through its own retail dispensaries and also supplies other licensed cannabis stores. Verano makes most of its money by selling cannabis products at its own dispensaries, which cuts out the middleman and helps protect its margins. The company operates in more than a dozen US states, with a focus on limited-license markets where regulators cap the number of competitors allowed — that restriction acts as a partial moat. With a market cap around $400 million, it is a mid-sized player in a fragmented industry. The biggest risk Verano faces is that cannabis remains federally illegal in the US, which blocks access to normal banking, raises taxes under IRS Section 280E, and limits the company's ability to grow cheaply.
Winston Score: 29/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (1/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $6.21
Market Cap: $459M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Other OTC

